Stacey GandlerBrand Nourishment
Pat PurcellMeeting Engagement
Liz KaneImpactful Strategy
Daniel SontupeMarket Access
Matthew DurhamOmnidynamic Marketing
Frank BurrellScientific Storytelling
Matt TurnerPatient Affordability
Joey CohenMedication Adherence
Paul TheisenPatient Acquisition
Suma Ramadas, PhDMedical Affairs
Amy GilesIncreasing Engagement
Bud BilanichSuccess Coach
David LinetskyPoint-of-Care Marketing
Brenda SnowAuthentic Patient Voice
In ALK-positive metastatic NSCLC patients, Zykadia median progression-free survival (PFS) was 16.6 months, compared ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email